Canary launches staking-enabled INJ ETF on Nasdaq

Canary’s INJC staked Injective exchange-traded fund began trading on Nasdaq on Nov. 5, according to Crypto.news. The product combines exposure to INJ with staking built into its structure, while the report also noted that Injective CEO rings the Nasdaq opening bell. No figures were provided for the amount of INJ held or staked by the fund. By Friday, the ETF reportedly had $16.12 million in assets and 600,000 shares outstanding. These were early figures cited by the sole outlet covering the launch; no second source was available to independently confirm the totals or provide additional details about fees, trading performance or the operation of the staking feature. The launch adds a Nasdaq-listed vehicle for investors seeking access to Injective with staking incorporated into the fund. The reported $16.12 million in assets indicates that the product had attracted meaningful participation by the end of its first trading week, based on Crypto.news’ figures. INJ was priced at $7.99, down 2.06% over 24 hours but up 10.43% over seven days, with a market capitalization of $798.56 million. The broader crypto market was broadly lower, with total capitalization at $2.56 trillion and Bitcoin down 1.62% over 24 hours. The Fear & Greed Index stood at 29, indicating a Fear reading. The ETF’s continuing asset growth and INJ’s seven-day performance are the main available measures to monitor following the debut.